Management of Constipation in Elderly Cancer Patients

Initial Assessment and Treatment

The American Society of Clinical Oncology recommends starting with polyethylene glycol (PEG) 17 g/day as first-line therapy for constipation in elderly cancer patients, due to its efficacy and safety profile 1, 2, 3, 4
Assess mobility status, as decreased mobility significantly impacts constipation risk and treatment selection in elderly cancer patients 1, 2, 3
Evaluate cardiac and renal comorbidities, as these influence laxative safety and selection 1, 2, 3
Review current medications, particularly opioid analgesics, diuretics, and cardiac glycosides, which can contribute to constipation 1, 4
Ensure adequate fluid intake, critical for determining safe laxative use 1, 2

The European Society for Medical Oncology suggests adding stimulant laxatives (senna or bisacodyl) as second-line therapy if PEG is insufficient or not tolerated 1, 2, 6
Osmotic laxatives (lactulose 15-30 mL daily) can serve as an alternative to PEG 5
Prophylactic laxatives are mandatory for patients on opioids, unless contraindicated by pre-existing diarrhea 4, 6

Ensure toilet access, particularly critical if mobility is decreased 1, 2, 3, 4, 6
Optimize toileting schedule, educating patients to attempt defecation twice daily, 30 minutes after meals 1, 2, 3, 4, 6
Provide dietetic support to address anorexia and chewing difficulties that reduce stool volume and consistency 1, 2, 3, 4, 6
Increase fluid intake to at least 1.5 liters daily 5

Manual disimpaction is the first step in managing fecal impaction, followed by isotonic saline enemas 2, 4, 5, 7
Initiate maintenance PEG 17 g/day to prevent recurrence after disimpaction 5

Monitor closely for dehydration and electrolyte imbalances, especially if on diuretics or cardiac glycosides 1, 2, 3, 6
Regularly assess renal function, particularly before using magnesium-containing products 6, 7
Monitor cardiac status if chronic heart failure is present and the patient is on cardiac medications 1, 2, 6
Adjust treatment regimens based on bowel movement frequency and patient-reported symptoms 6